As filed with the Securities and Exchange Commission
on November 4, 2024
Registration No. 333-264855
Registration No. 333-271720
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
MAGNERA CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
| Pennsylvania |
|
23-0628360 |
|
(State or Other Jurisdiction of
Incorporation or Organization) |
|
(I.R.S. Employer
Identification Number) |
9335 Harris Corners Pkwy, Suite 300
Charlotte, North Carolina 28269
(Address of Principal Executive Offices) (Zip
Code)
Magnera Corporation 2024 Omnibus Incentive
Plan
Glatfelter Corporation 2022 Long-Term Incentive
Plan
(Full Title of the Plan)
Jill L. Urey
Executive Vice President, General Counsel and Corporate Secretary
9335 Harris Corners Pkwy, Suite 300
Charlotte, North Carolina 28269
(866) 744-7380
(Name, Address and Telephone Number, Including
Area Code, of Agent for Service)
Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of
“large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth
company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer |
¨ |
|
Accelerated filer |
x |
| |
|
|
|
|
| Non-accelerated filer |
¨ |
|
Smaller reporting company |
¨ |
| |
|
|
|
|
| |
|
|
Emerging growth company |
¨ |
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 7(a)(2)(B) of the Securities Act. ¨
EXPLANATORY NOTE
Magnera Corporation (formerly Glatfelter Corporation,
the “Company”) filed with the Securities and Exchange Commission Registration Statements on Form S-8
on May 11, 2022 (file No. 333-264855) and May 8, 2023 (File No. 333-271720) (collectively, the “Registration
Statements”) registering an aggregate of 434,099 shares of the Company’s common stock, par value $0.01 per share (“Common
Stock”) issuable under the Glatfelter Corporation 2022 Long-Term Incentive Plan (the “2022 Plan”).
On October 23, 2024, the Company’s
shareholders approved the Magnera Corporation 2024 Omnibus Incentive Plan (the “2024 Plan”), and as of such date (the “Effective
Date”) the 2024 Plan became effective and no further awards were authorized for grant under the 2022 Plan. The total number of shares
of Common Stock authorized for issuance under the 2024 Plan includes, in addition to 6,538,461 new shares of Common Stock (registered
on a new Registration Statement on Form S-8 filed contemporaneously with this Post-Effective Amendment), a number of shares of Common
Stock (a) that remained available for issuance under the 2022 Plan immediately prior to the Effective Date and (b) underlying
any equity awards previously granted under the 2022 Plan as of the Effective Date that, terminate, expire, or are canceled, forfeited,
surrendered without having been exercised, vested, or settled in full or are paid in cash, as applicable, on or after the Effective Date
(collectively, the shares described in clauses (a) and (b) above, the “Rollover Shares”). Immediately prior to the
Effective Date, 26,431 shares of Common Stock remained available for grant under the 2022 Plan and 332,831 shares of Common Stock were
underlying outstanding equity awards under the 2022 Plan.
The Company is filing this Post-Effective Amendment
No. 1 to the Registration Statements (the “Post-Effective Amendment”) pursuant to Item 512(a)(1)(iii) of Regulation
S-K to cover the offering of the Rollover Shares under the 2024 Plan. No additional shares of Common Stock are being registered hereby.
All share amounts reflect a reverse stock split
of the Common Stock at a ratio of 1-for-13 effected on November 4, 2024.
PART I
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
The document(s) containing information specified
by Part I of this Registration Statement will be sent or given to participants in the Magnera Corporation 2024 Omnibus Incentive
Plan as specified in Rule 428(b)(1) promulgated by the Securities and Exchange Commission (the “Commission”) under
the Securities Act of 1933 (the “Securities Act”). Such documents are not being filed with the Commission but constitute (along
with the documents incorporated by reference into the Registration Statement pursuant to Item 3 of Part II hereof), a prospectus
that meets the requirements of Section 10(a) of the Securities Act.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The following documents that the Company has previously
filed with the Commission are incorporated herein by reference:
| (2) | The Company’s Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2024, June 30, 2024 and
September 30, 2024, filed with the Commission on May 9, 2024, August 8, 2024 and October 30, 2024, respectively; |
| (3) | The
Company’s Current Reports on Form 8-K filed with the Commission on February 7, 2024 (as amended on
Form 8-K/A filed with the Commission on February 12,
2024), March 5,
2024, April 11,
2024, May 14,
2024 (as amended on Form 8-K/A filed with the Commission on May 14,
2024), May 30,
2024, August 16,
2024, October 11,
2024, October 22,
2024 and October 23,
2024; and |
| (4) | The description of the Company’s Common Stock set forth under the caption “Description of Capital Stock of Glatfelter
– Description of Common Stock” in the Company’s Registration Statement on Form S-4 filed with the Commission on August 23, 2024, including any subsequent amendment or report filed for the purpose of updating the description of the Company’s
Common Stock contained therein. |
All documents filed by the Company subsequent
to the date of this Registration Statement pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934,
as amended (the “Exchange Act”), and prior to the filing of a post-effective amendment which indicates that all securities
offered hereby have been sold or which deregisters all such securities then remaining unsold, shall be deemed to be incorporated by reference
in this Registration Statement and to be a part hereof from the date of filing of such documents.
Any statement contained in the documents incorporated
or deemed to be incorporated by reference in this Registration Statement shall be deemed to be modified, superseded or replaced for purposes
of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document which also
is incorporated or deemed to be incorporated by reference in this Registration Statement modifies, supersedes or replaces such statement.
Any such statement so modified, superseded or replaced shall not be deemed, except as so modified, superseded or replaced, to constitute
a part of this Registration Statement.
No document or information deemed to be furnished
and not filed in accordance with rules of the Commission shall be deemed to be incorporated herein by reference unless such document
or information expressly provides to the contrary.
Item 4. Description of Securities.
Not applicable.
Item 5. Interests of Named Experts and Counsel.
Not applicable.
Item 6. Indemnification of Directors and Officers.
The Company
is incorporated under the laws of the Commonwealth of Pennsylvania.
Under Sections
1741 and 1742 of the Pennsylvania Business Corporation Law (“PBCL”), a business corporation has the power to indemnify any
person who was or is a party, or is threatened to be made a party, to any threatened, pending or completed action or proceeding, whether
civil, criminal, administrative or investigative, by reason of the fact that such person is or was a director, officer or representative
of the corporation, or is or was serving at the request of the corporation as a director, officer or representative of another corporation
or other enterprise, against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and
reasonably incurred by such person in connection with such action or proceeding, if such person acted in good faith and in a manner he
or she reasonably believed to be in, or not opposed to, the best interests of the corporation, and, with respect to any criminal proceeding,
had no reasonable cause to believe his conduct was unlawful. In the case of a threatened, pending or completed action or proceeding by
or in the right of the corporation, such indemnification only covers expenses and excludes judgments and amounts paid in settlement with
respect to such action or proceeding, and no indemnification can be made for expenses if such person has been adjudged to be liable to
the corporation unless, and only to the extent that, a court determines upon application that, despite the adjudication of liability but
in view of all the circumstances, such person is fairly and reasonably entitled to indemnity for the expenses that the court deems proper.
In addition,
PBCL Section 1744 provides that, unless ordered by a court, any indemnification referred to above shall be made by the corporation
only as authorized in the specific case upon a determination that indemnification is proper in the circumstances because the indemnitee
has met the applicable standard of conduct. Such determination shall be made:
(1)
by the board of directors by a majority vote of a quorum consisting of directors who were not parties to the action or proceeding;
(2)
if such a quorum is not obtainable, or if obtainable and a majority vote of a quorum of disinterested directors so directs, by independent
legal counsel in a written opinion; or
(3)
by the shareholders.
Notwithstanding
the above, PBCL Section 1743 provides that to the extent that a present or former director, officer or representative of a business
corporation is successful on the merits or otherwise in defense of any action or proceeding referred to above, or in defense of any claim,
issue or matter therein, such person shall be indemnified against expenses (including attorneys’ fees) actually and reasonably incurred
by such person in connection therewith.
Further,
PBCL Section 1745 provides that expenses (including attorneys’ fees) incurred by an officer, director or representative of
a business corporation in defending any such action or proceeding may be paid by the corporation in advance of the final disposition of
the action or proceeding upon receipt of an undertaking by or on behalf of such officer, director or representative to repay the amount
advanced if it is ultimately determined that the indemnitee is not entitled to be indemnified by the corporation.
Also, PBCL
Section 1746 provides that the indemnification and advancement of expenses provided by, or granted pursuant to, the foregoing provisions
is not exclusive of any other rights to which a person seeking indemnification or advancement of expenses may be entitled under any bylaw,
agreement, vote of shareholders or disinterested directors or otherwise, and that indemnification may be granted under any bylaw, agreement,
vote of shareholders or directors or otherwise for any action taken or any failure to take any action and may be made whether or not the
corporation would have the power to indemnify the person under any other provision of law and whether or not the indemnified liability
arises or arose from any threatened, pending or completed action by or in the right of the corporation; provided, however, that no indemnification
may be made in any case where the act or failure to act giving rise to the claim for indemnification is determined by a court to have
constituted willful misconduct or recklessness.
Article III
of the Company’s Bylaws provide that directors or officers of the Company, or of any of its subsidiaries, who was or is an “authorized
representative” of the Company (which shall mean for the purposes of Item 20, a director or officer of the Company, or a person
serving at the request of, for the convenience of, or to represent the interests of, the Company as a director, officer, employee partner,
agent, manager, member, fiduciary, trustee or other representative of another corporation, partnership, limited liability company, joint
venture, trust, employee benefit plan or other enterprise) shall be indemnified as of right to the fullest extent not prohibited by law
in connection with any actual or threatened action, suit, appeal, investigation (including any internal investigation), inquiry, hearing,
mediation, arbitration, other alternative dispute mechanism or other proceeding of any nature, whether civil, criminal, administrative,
regulatory, legislative, investigative or arbitrative, whether formal or informal, and whether brought by or in the right of the Company,
its shareholders, the Company’s board of directors, any duly authorized committee of the Company’s board of directors, a governmental
agency or instrumentality, a self-regulatory organization or otherwise, by reason of the fact that such person was or is an authorized
representative of the Company; provided, however, that the Company will not indemnify any authorized representative in connection with
a proceeding (or part thereof) initiated by such person unless such proceeding (or part thereof) is brought by the authorized representative
due to the failure of the Company to pay indemnification provided under Sections 3.1, 3.2 or 3.3 of the Company’s Bylaws and the
authorized representative is successful in such proceeding.
PBCL Section 1747
permits a business corporation to purchase and maintain insurance on behalf of any person who is or was a director, officer or representative
of the corporation, or is or was serving at the request of the corporation as a director, officer or representative of another corporation
or other enterprise, against any liability asserted against such person and incurred by him in any such capacity, or arising out of his
status as such, whether or not the corporation would have the power to indemnify the person against such liability under the provisions
described above.
Article III
of the Company’s Bylaws provides that the Company may purchase and maintain insurance to protect the Company and its authorized
representatives against any liability asserted against such person and incurred by such person in respect of the service of such person,
upon such terms and conditions as the board of directors of the Company deems appropriate.
The Company
maintains directors’ and officers’ liability insurance covering its directors and officers with respect to liabilities, including
liabilities under the Securities Act, which they may incur in connection with their serving as such. Under this insurance, the Company
may receive reimbursement for amounts as to which the directors and officers are indemnified by the Company under the Article III
of the Company’s Bylaws. Such insurance also provides certain additional coverage for the directors and officers against certain
liabilities even though such liabilities may not be covered by Article III of the Company’s Bylaws.
As permitted
by PBCL Section 1713, and as the Company’s Bylaws provide, no director shall be personally liable for monetary damages for
any action taken, or any failure to take any action, on or after January 27, 1987, unless such director has breached or failed to
perform the duties of the office as provided for under Section 1713 of the PBCL, as amended, and the breach or failure to perform
constitutes self-dealing, willful misconduct or recklessness. The PBCL states that this exculpation from liability does not apply to the
responsibility or liability of a director pursuant to any criminal statute or the liability of a director for the payment of taxes pursuant
to federal, state or local law. It is uncertain whether this provision will control with respect to liabilities imposed upon directors
by federal law, including federal securities laws. PBCL Section 1715(d) creates a presumption, subject to exceptions, that a
director acted in the best interests of the corporation. PBCL Section 1712, in defining the standard of care a director owes to the
corporation, provides that a director stands in a fiduciary relation to the corporation and must perform his duties as a director or as
a member of any committee of the board of directors in good faith, in a manner he reasonably believes to be in the best interests of the
corporation and with such care, including reasonable inquiry, skill and diligence, as a person of ordinary prudence would use under similar
circumstances.
The Company
also has indemnification agreements with all of the Company’s executive officers and directors (collectively, “Indemnitees”).
These agreements provide that the Indemnitees will be protected as promised in the Company’s Bylaws (regardless of, among other
things, any amendment to or revocation of the Company’s Bylaws or any change in the composition of the Company’s board of
directors or an acquisition transaction relating to the Company) and advanced expenses to the fullest extent of the law and as set forth
in the indemnification agreements. These agreements also provide, to the extent insurance is maintained, for the continued coverage of
the Indemnitees under the Company’s director and officer insurance policies.
The foregoing
is only a general summary of certain aspects of the PBCL and the Company’s Bylaws dealing with indemnification of directors and
officers and does not purport to be complete.
Item 7. Exemption from Registration Claimed.
Not applicable.
Item 8. Exhibits.
The exhibits listed below in the “Index to
exhibits” are part of this Registration Statement on Form S-8 and are numbered in accordance with Item 601 of Regulation S-K.
Item 9. Undertakings.
| |
(a) |
The undersigned Company hereby undertakes: |
| |
(1) |
To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement: |
| |
(i) |
To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933; |
| |
(ii) |
To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective Registration Statement; |
| |
(iii) |
To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement; |
provided, however, that paragraphs (a)(l)(i) and
(a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained
in reports filed with or furnished to the Commission by the Company pursuant to Section 13 or Section 15(d) of the Securities
Exchange Act of 1934 that are incorporated by reference in the Registration Statement;
| |
(2) |
That for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new Registration Statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
| |
(3) |
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. |
| |
(b) |
The undersigned Company hereby undertakes that, for the purposes of determining any liability under the Securities Act of 1933, each filing of the Company’s annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the Registration Statement shall be deemed to be a new Registration Statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
| |
(c) |
Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Company pursuant to the foregoing provisions, or otherwise, the Company has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Company of expenses incurred or paid by a director, officer or controlling person of the Company in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Company will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue. |
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Company
certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused
this Post-Effective Amendment No. 1 to Form S-8 Registration Statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of Charlotte, State of North Carolina, on November 4, 2024.
| |
Magnera Corporation |
| |
|
|
| |
By: |
/s/
Curtis L. Begle |
| |
|
Name: Curtis L. Begle |
| |
|
Title: Chief Executive Officer |
Power of Attorney
Each of the undersigned officers and directors of Magnera Corporation
hereby constitutes and appoints Curtis L. Begle, James Till and Jill Urey and each of them and each of them, his or her true and lawful
attorneys-in-fact and agents, each with full power of substitution and re-substitution, for him or her and in his or her name, place and
stead, in any and all capacities, to sign the Registration Statement of Magnera Corporation on Form S-8, and any other registration
statement relating to the same offering (including any and all amendments thereto (including post-effective amendments)), and to file
the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting
unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite
or necessary to be done in connection therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying
and confirming all that each of said attorneys-in-fact and agents, or his substitute or substitutes, may lawfully do or cause to be done
by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this Registration
Statement has been signed by the following persons in the capacities set forth opposite their names and on the dates indicated.
|
Signature |
|
Title |
|
Date |
| |
|
|
|
|
/s/ Curtis L.
Begle
Curtis L. Begle |
|
Chief Executive Officer and Director
(Principal Executive Officer) |
|
November 4, 2024 |
| |
|
|
|
|
/s/ James Till
James Till |
|
Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer) |
|
November 4, 2024 |
| |
|
|
|
|
/s/ Kevin M.
Fogarty
Kevin M. Fogarty |
|
Chairman of the Board of Directors |
|
November 4, 2024 |
| |
|
|
|
|
/s/ Bruce Brown
Bruce Brown |
|
Director |
|
November 4, 2024 |
| |
|
|
|
|
/s/ Michael
S. Curless
Michael S. Curless |
|
Director |
|
November 4, 2024 |
| |
|
|
|
|
/s/ Thomas M.
Fahnemann
Thomas M. Fahnemann |
|
Director |
|
November 4, 2024 |
| |
|
|
|
|
/s/ Samantha
J. Marnick
Samantha J. Marnick |
|
Director |
|
November 4, 2024 |
| |
|
|
|
|
/s/ Carl J.
Rickertsen
Carl J. Rickertsen |
|
Director |
|
November 4, 2024 |
| |
|
|
|
|
|
/s/ Thomas E.
Salmon |
|
Director |
|
November 4, 2024 |
| Thomas E. Salmon |
|
|
|
| |
|
|
|
|
| /s/ Mary Dean Hall |
|
Director |
|
November 4, 2024 |
| Mary Dean Hall |
|
|
|
INDEX TO EXHIBITS
* Filed
herewith.
EXHIBIT 5.1
November 4, 2024
Magnera Corporation
4350 Congress Street, Suite 600
Charlotte, North Carolina 28209
Re: Magnera Corporation Post-Effective Amendment on Form S-8POS
Filed on November 4, 2024
Ladies and Gentlemen:
We have acted as counsel to Magnera Corporation, a Pennsylvania corporation
(the “Company”), in connection with its filing of a Post-Effective Amendment No. 1 (the “Post-Effective Amendment”)
to the Registration Statements on Form S-8 filed by the Company with the Securities and Exchange Commission (the “SEC”) on
May 11, 2022 (File No. 333-264855) and May 8, 2023 (File No. 333-271720) (collectively, the “Registration Statements”) under
the Securities Act of 1933, as amended (the “Act”) relating to the registration of the offer and sale of 359,262 shares of
common stock, par value $0.01 per share, of the Company (the “Common Stock”), which may be issued under the Magnera Corporation
2024 Omnibus Incentive Plan (the “2024 Plan”), which shares were originally authorized for issuance under the Glatfelter Corporation
2022 Long-Term Incentive Plan (the “2022 Plan”).
On October 23, 2024, the Company’s shareholders approved the
2024 Plan, and as of such date (the “Effective Date”) the 2024 Plan became effective and no further awards were authorized
for grant under the 2022 Plan. Pursuant to the terms of the 2024 Plan, the shares of Common Stock authorized for issuance under the 2024
Plan includes the shares of Common Stock (a) that remained available for issuance under the 2022 Plan immediately prior to the Effective
Date and (b) underlying any equity awards previously granted under the 2022 Plan as of the Effective Date that, terminate, expire, or
are canceled, forfeited, surrendered without having been exercised, vested, or settled in full or are paid in cash, as applicable, on
or after the Effective Date (collectively, the “Rollover Shares”). Immediately prior to the Effective Date, 26,431 shares
of Common Stock remained available for grant under the 2022 Plan and 332,831 shares of Common Stock were underlying outstanding equity
awards under the 2022 Plan.
In connection with this opinion letter, we have examined the Registration
Statements and originals, or copies certified or otherwise identified to our satisfaction, of (i) the Amended and Restated Articles
of Incorporation of the Company, as amended to date, (ii) the Amended and Restated By-Laws of the Company, as amended to
date, (iii) certain resolutions of the Company’s Board of Directors relating to the Registration Statements and the 2024 Plan,
(iv) the 2022 Plan, (v) the 2024 Plan, and (vi) such other documents, records and other instruments as we have deemed appropriate
for purposes of the opinions set forth herein.
We have assumed the genuineness of all signatures, the legal capacity
of all natural persons, the authenticity of the documents submitted to us as originals, the conformity with the originals of all documents
submitted to us as certified, facsimile or photostatic copies and the authenticity of the originals of all documents submitted to us as
copies. With respect to matters of fact relevant to our opinions as set forth below, we have relied upon certificates of officers of the
Company, representations made by the Company in documents examined by us, and representations of officers of the Company. We have also
obtained and relied upon such certificates and assurances from public officials as we have deemed necessary for the purposes of our opinions
set forth below.
Subject to the foregoing and the other matters set forth herein, we
are of the opinion, as of the date hereof that the Rollover Shares have been duly authorized by the Company and, when issued by the Company
in accordance with the provisions of the 2024 Plan, will be validly issued, fully paid, and non-assessable.
We hereby consent to the use of this opinion as Exhibit 5.1 to
the Registration Statement. In giving such consent, we do not hereby admit that we are acting within the category of persons whose consent
is required under Section 7 of the Act or the rules or regulations of the SEC thereunder.
The opinions expressed herein are limited to the Federal laws of the
United States and the Pennsylvania Business Corporation Law of 1988, as amended.
|
Very truly yours, |
|
| |
|
| /s/ Morgan, Lewis & Bockius LLP |
|
| |
Morgan, Lewis & Bockius
LLP |
|
| |
|
|
| |
2222
Market Street
Philadelphia, PA 19103-3007
United States |
+1.215.963.5000
+1.215.963.5001
|
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation
by reference in this Post-Effective Amendment No. 1 to Registration Statements on Form S-8 of our reports dated February 28,
2024, relating to the financial statements of Glatfelter Corporation (the “Company”), and the effectiveness of the Company's
internal control over financial reporting, appearing in the Annual Report on Form 10-K of the Company for the year ended December 31,
2023.
/s/ DELOITTE & TOUCHE
LLP
Charlotte, North Carolina
November 4, 2024
Exhibit 23.3
Consent of Independent Registered Public Accounting
Firm
We consent to the incorporation by reference in the Post-effective
Amendment No. 1 to the Registration Statement (Form S-8) of Magnera Corporation’s (formerly Glatfelter Corporation) 2024
Omnibus Incentive Plan and Glatfelter Corporation’s 2022 Long-Term Incentive Plan of our report dated May 8, 2024, with respect
to the combined financial statements of Spinco, included in Glatfelter Corporation’s Registration Statement (Form S-4 No. 333-281733)
and incorporated by reference in Magnera Corporation’s Current Report on Form 8-K dated November 4, 2024, filed with the
Securities and Exchange Commission.
/s/ ERNST & YOUNG LLP
Indianapolis, Indiana
November 4, 2024
Grafico Azioni Glatfelter (NYSE:GLT)
Storico
Da Ott 2024 a Dic 2024
Grafico Azioni Glatfelter (NYSE:GLT)
Storico
Da Dic 2023 a Dic 2024
